Figure 3.
Peripheral arthritis: change from OCTAVE Induction baseline at week 8 or early termination (A) and change from OCTAVE Sustain baseline at week 52 or early termination (B), by EIM status.
BID, twice daily; BL, baseline; EIM, extraintestinal manifestation; n, number of patients in the specified category with non-missing values at week 8/early termination or week 52/early termination.